Cited by CrossRef (18)
- Somin Kwon, Michiyo Iba, Changyoun Kim, Eliezer Masliah. Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets. Neurotherapeutics 2020;17:935

- María Pascual, Maria Calvo‐Rodriguez, Lucía Núñez, Carlos Villalobos, Juan Ureña, Consuelo Guerri. Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damage. IUBMB Life 2021;73:900

- Sindhu Menon, Sabrina Armstrong, Amir Hamzeh, Naomi P. Visanji, Sergio Pablo Sardi, Anurag Tandon. Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies. Front. Neurol. 2022;13

- Changyoun Kim, Somin Kwon, Michiyo Iba, Brian Spencer, Edward Rockenstein, Michael Mante, Anthony Adame, Soo Jean Shin, Jerel A. Fields, Robert A. Rissman, Seung-Jae Lee, Eliezer Masliah. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells. Exp Mol Med 2021;53:281

- Stefano Federico, Luca Pozzetti, Alessandro Papa, Gabriele Carullo, Sandra Gemma, Stefania Butini, Giuseppe Campiani, Nicola Relitti. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. J. Med. Chem. 2020;63:13466

- Michiyo Iba, Changyoun Kim, Michelle Sallin, Somin Kwon, Anjali Verma, Cassia Overk, Robert A. Rissman, Ranjan Sen, Jyoti Misra Sen, Eliezer Masliah. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models. J Neuroinflammation 2020;17

- Silvia Squillace, Daniela Salvemini. Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions. Trends in Pharmacological Sciences 2022;43:726

- Marcell P. Szabo, Michiyo Iba, Avindra Nath, Eliezer Masliah, Changyoun Kim. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS. Exp Mol Med 2022;54:447

- Marija Vidović, Milena G. Rikalovic. Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches. Cells 2022;11:1732

- Fan Bu, Ruiqian Guan, Wanyu Wang, Zhao Liu, Shijie Yin, Yonghou Zhao, Jianbo Chai. Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review. 2022;101:e32100

- Panagiota Mavroeidi, Maria Xilouri. Neurons and Glia Interplay in α-Synucleinopathies. IJMS 2021;22:4994

- Margaux Teil, Marie-Laure Arotcarena, Emilie Faggiani, Florent Laferriere, Erwan Bezard, Benjamin Dehay. Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts. Biomolecules 2020;10:391

- Changyoun Kim, Alexandria Beilina, Nathan Smith, Yan Li, Minhyung Kim, Ravindran Kumaran, Alice Kaganovich, Adamantios Mamais, Anthony Adame, Michiyo Iba, Somin Kwon, Won-Jae Lee, Soo-Jean Shin, Robert A. Rissman, Sungyong You, Seung-Jae Lee, Andrew B. Singleton, Mark R. Cookson, Eliezer Masliah. LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies. Sci. Transl. Med. 2020;12

- Gianluigi Forloni, Pietro La Vitola, Claudia Balducci. Oligomeropathies, inflammation and prion protein binding. Front. Neurosci. 2022;16

- Valentina Oppo, Marta Melis, Melania Melis, Iole Tomassini Barbarossa, Giovanni Cossu. “Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease. Front. Aging Neurosci. 2020;12

- Pragya Komal, S.K.V. Manjari, Raad Nashmi. An opinion on the debatable function of brain resident immune protein, T-cell receptor beta subunit in the central nervous system. IBRO Neuroscience Reports 2022;13:235

- Gianluigi Forloni. Alpha Synuclein: Neurodegeneration and Inflammation. IJMS 2023;24:5914

- Michiyo Iba, Changyoun Kim, Jazmin Florio, Michael Mante, Anthony Adame, Edward Rockenstein, Somin Kwon, Robert Rissman, Eliezer Masliah. Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models. Front. Neurosci. 2020;14
